# Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-antitumor-activity-of-dostarlimab-in-patients-with-advanced-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ana Oaknin,Lucy Gilbert,Anna V. Tinker,Jubilee Brown,Cara Mathews,Joshua Z. Press,Renaud Sabatier,David M. O’Malley,Vanessa Samouëlian,Valentina Boni,Linda Duska,Sharad Ghamande,Prafull Ghatage,Rebecca Kristeleit,Charles A. Leath,Wei Guo,Ellie Im,S. Zildjian,Xinwei Han,Tao Duan,Jennifer Veneris,Bhavana Pothuri |
| Citations | 332 |
| DOI | 10.1136/jitc-2021-003777 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1136/jitc-2021-003777 |
| OpenAlex ID | https://openalex.org/W4206897023 |
| PMID | 35064011 |
| Type | article |
| Year | 2022 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Rebecca Kristeleit](https://scholariq.org/researchers/rebecca-kristeleit/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.